company background image
JULPHAR logo

Gulf Pharmaceutical Industries P.S.C ADX:JULPHAR Stock Report

Last Price

د.إ0.86

Market Cap

د.إ993.5m

7D

-0.2%

1Y

1.2%

Updated

19 Jun, 2024

Data

Company Financials +

Gulf Pharmaceutical Industries P.S.C.

ADX:JULPHAR Stock Report

Market Cap: د.إ993.5m

JULPHAR Stock Overview

Manufactures and sells medicines, drugs, and other pharmaceutical, medical, cosmetic compounds in the United Arab Emirates, other GCC countries, and internationally.

JULPHAR fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends0/6

Rewards

Risk Analysis

No risks detected for JULPHAR from our risk checks.

Gulf Pharmaceutical Industries P.S.C. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Gulf Pharmaceutical Industries P.S.C
Historical stock prices
Current Share Priceد.إ0.86
52 Week Highد.إ1.41
52 Week Lowد.إ0.70
Beta0.27
1 Month Change-8.51%
3 Month Change-13.65%
1 Year Change1.18%
3 Year Change-43.79%
5 Year Change-69.22%
Change since IPO-41.58%

Recent News & Updates

Gulf Pharmaceutical Industries P.S.C.'s (ADX:JULPHAR) Share Price Boosted 42% But Its Business Prospects Need A Lift Too

Jan 15
Gulf Pharmaceutical Industries P.S.C.'s (ADX:JULPHAR) Share Price Boosted 42% But Its Business Prospects Need A Lift Too

Recent updates

Gulf Pharmaceutical Industries P.S.C.'s (ADX:JULPHAR) Share Price Boosted 42% But Its Business Prospects Need A Lift Too

Jan 15
Gulf Pharmaceutical Industries P.S.C.'s (ADX:JULPHAR) Share Price Boosted 42% But Its Business Prospects Need A Lift Too

Gulf Pharmaceutical Industries P.S.C.'s (ADX:JULPHAR) Price Is Right But Growth Is Lacking

Nov 04
Gulf Pharmaceutical Industries P.S.C.'s (ADX:JULPHAR) Price Is Right But Growth Is Lacking

Gulf Pharmaceutical Industries P.S.C's (ADX:JULPHAR) Solid Profits Have Weak Fundamentals

Mar 26
Gulf Pharmaceutical Industries P.S.C's (ADX:JULPHAR) Solid Profits Have Weak Fundamentals

Gulf Pharmaceutical Industries P.S.C's(ADX:JULPHAR) Share Price Is Down 59% Over The Past Five Years.

Feb 08
Gulf Pharmaceutical Industries P.S.C's(ADX:JULPHAR) Share Price Is Down 59% Over The Past Five Years.

Here's What Gulf Pharmaceutical Industries P.S.C.'s (ADX:JULPHAR) Shareholder Ownership Structure Looks Like

Dec 14
Here's What Gulf Pharmaceutical Industries P.S.C.'s (ADX:JULPHAR) Shareholder Ownership Structure Looks Like

Shareholder Returns

JULPHARAE PharmaceuticalsAE Market
7D-0.2%-1.7%-0.4%
1Y1.2%2.1%-5.0%

Return vs Industry: JULPHAR matched the AE Pharmaceuticals industry which returned 2.1% over the past year.

Return vs Market: JULPHAR exceeded the AE Market which returned -5% over the past year.

Price Volatility

Is JULPHAR's price volatile compared to industry and market?
JULPHAR volatility
JULPHAR Average Weekly Movement2.9%
Pharmaceuticals Industry Average Movement5.2%
Market Average Movement3.8%
10% most volatile stocks in AE Market7.8%
10% least volatile stocks in AE Market2.2%

Stable Share Price: JULPHAR has not had significant price volatility in the past 3 months.

Volatility Over Time: JULPHAR's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1980n/aBasel Nimer Ziyadehwww.julphar.net

Gulf Pharmaceutical Industries P.S.C., together with its subsidiaries, manufactures and sells medicines, drugs, and other pharmaceutical, medical, cosmetic compounds in the United Arab Emirates, other GCC countries, and internationally. It operates through Manufacturing, Plant, Investment, and Others segment. The company provides generic medicines for pain management, GIT and endocrine, antiviral, respiratory, anti-infectives, cardio care, wound care, dermatology, CNS and psychiatry, biotechnology, gynecology women care, anemia, antibiotics, inflammation, and erectile dysfunction, as well as consumer care products, mouth wash, and vitamins and supplements.

Gulf Pharmaceutical Industries P.S.C. Fundamentals Summary

How do Gulf Pharmaceutical Industries P.S.C's earnings and revenue compare to its market cap?
JULPHAR fundamental statistics
Market capد.إ993.50m
Earnings (TTM)-د.إ98.00m
Revenue (TTM)د.إ1.62b

0.6x

P/S Ratio

-10.1x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
JULPHAR income statement (TTM)
Revenueد.إ1.62b
Cost of Revenueد.إ1.06b
Gross Profitد.إ562.20m
Other Expensesد.إ660.20m
Earnings-د.إ98.00m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.085
Gross Margin34.64%
Net Profit Margin-6.04%
Debt/Equity Ratio123.1%

How did JULPHAR perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.